US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM on April 21 for "Molecular biomarkers and targets for Fuchs' endothelial corneal dystrophy and glaucoma" (Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,868, issued on April 21, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Molecular biomarkers and targets for Fuchs' endothelial corneal dystrophy and glaucoma" was invented by Venkateswara Vinod Mootha (Coppell, Texas), David R. Corey (Dallas), Jiaxin Hu (Coppell, Texas) and Yongjun Chu (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Molecular biomarkers relating to Fuchs' endothelial corneal dystrophy (FECD), glaucoma, and other degenerative ocular diseases are provided, as well as methods for using such biomarkers methods of treatment. These biomarkers may be used to monitor the progression of FECD...